IndraLab

Statements

MYSM1 inhibits biosynthetic process. 1 / 1

| 1

reach

"Importantly, the treatment with MYSM1 represses the synthesis of type I IFNs and pro-inflammatory cytokines in the PBMCs of SLE patients.Therefore, MYSM1 plays a pivotal role in the restriction of inn[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

33086059

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

MYSM1 inhibits biosynthetic process. 1 / 1

INDRA sources:

Databases

Reading